Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board changes

30 May 2024 12:00

RNS Number : 4436Q
Xaar PLC
30 May 2024
 

30 May 2024

 

Xaar plc

 

Board changes

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, is pleased to announce the appointment of Dr Inken Braunschmidt as Independent Non-Executive Director.

 

Inken joins the Board with effect from 1 June 2024 and on appointment will be a member of the Audit, Remuneration and Nomination Committees.

 

As previously disclosed, Alison Littley had notified the Board of her intention to step down as a Non-Executive Director of the Company during 2024. It is now confirmed that Alison will leave the Board on 30 June 2024. Inken will be appointed as Chair of Remuneration Committee on 1 July 2024.

 

Richard Amos, Non-Executive Director, will replace Alison Littley as the Company's Senior Independent Director on 1 July 2024.

 

Inken Braunschmidt is currently a non-executive director of James Fisher and Sons plc, listed on the London Stock Exchange, and Chair of its Remuneration Committee as well as a member of the Audit and Nomination Committees. She was Chief Innovation and Digital Officer and member of the Executive Board of Halma plc until 2023. Prior to joining Halma plc in 2017, Inken spent 13 years at RWE AG, the German energy giant, and its renewables subsidiary innogy SE, where she held various international leadership roles focusing on strategy, innovation, digital transformation and change management. Inken studied Business Administration, Innovation & Technology Management at Kiel University and did her PhD thesis in Technology Management. Inken is member of the Digital Programme Board of the Royal Academy of Engineering.

 

 

Andrew Herbert, Chairman, commented:

 

"We are delighted to welcome Inken to the Board and her expertise and experience in international electronic engineering and digital innovation and transformation are very relevant to the opportunities and challenges that face Xaar. I would like to thank Alison for her contribution and commitment to the Board of Xaar as a director since 2020 and wish her the very best for the future."

 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Inken Braunschmidt.

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURAWRSAUVORR
Date   Source Headline
23rd Dec 20117:02 amRNSTotal Voting Rights
23rd Dec 20117:01 amRNSBlocklisting Interim Review
23rd Dec 20117:00 amRNSIssue of Options
24th Nov 20119:58 amRNSHolding(s) in Company
18th Nov 20113:23 pmRNSBlocklisting Interim Review
17th Nov 20115:31 pmRNSHolding(s) in Company
21st Oct 201112:06 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSInterim Management Statement
11th Oct 201112:24 pmRNSHolding(s) in Company
4th Oct 201112:59 pmRNSTotal Voting Rights
30th Sep 20119:04 amRNSDirector/PDMR Shareholding
26th Sep 20115:50 pmRNSHolding(s) in Company
26th Aug 20115:21 pmRNSHolding(s) in Company
23rd Aug 20114:14 pmRNSDirector/PDMR Shareholding
18th Aug 20111:55 pmRNSHalf Yearly Report - Replacement
18th Aug 20117:00 amRNSInterim Management Statement
5th Aug 20112:59 pmRNSAdditional Listing
7th Jul 20117:00 amRNSInterim Trading Update
21st Jun 20114:34 pmRNSHolding(s) in Company
15th Jun 20117:00 amRNSHolding(s) in Company
9th Jun 20112:48 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSBoard Changes
17th May 20114:46 pmRNSResult of AGM
5th May 20117:00 amRNSNotice of 2011 AGM and AFR 2010
27th Apr 201111:54 amRNSGrant of Options
21st Apr 20117:00 amRNSInterim Management Statement
7th Apr 20118:00 amRNSDirector/PDMR Shareholding
31st Mar 201110:20 amRNSDirector/PDMR Shareholding
22nd Mar 20117:00 amRNSFinal Results
9th Mar 20114:14 pmRNSHolding(s) in Company
3rd Mar 20118:58 amRNSHolding(s) in Company
20th Jan 20117:00 amRNSYear End Trading Update
21st Dec 201011:12 amRNSGrant of Options
14th Dec 20107:00 amRNSDirectorate Change
18th Nov 20101:58 pmRNSDirector/PDMR Shareholding
15th Nov 201010:51 amRNSHolding(s) in Company
8th Nov 20102:51 pmRNSHolding(s) in Company
8th Nov 20101:48 pmRNSResult of General Meeting
8th Nov 20107:00 amRNSResults of the Placing and Open Offer
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20107:00 amRNSIMS and fundraising
21st Oct 20107:00 amRNSIMS and fundraising
20th Sep 201011:57 amRNSHoldings in Company: Released in Error
20th Sep 201011:26 amRNSHolding(s) in Company
6th Sep 201010:03 amRNSHolding(s) in Company
6th Sep 201010:00 amRNSHolding(s) in Company
2nd Sep 20104:04 pmRNSHolding(s) in Company
24th Aug 201012:44 pmRNSHolding(s) in Company
18th Aug 20107:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.